NCT05594680View on ClinicalTrials.gov

Cilostazol and Methotrexate in Rheumatoid Arthritis

PHASE3RecruitingINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

October 1, 2022

Primary Completion Date

November 1, 2024

Study Completion Date

November 1, 2024

Conditions
Rheumatoid Arthritis
Interventions
DRUG

Cilostazol

Cilostazol 50 MG

DRUG

Methotrexate

Methotrexate (MTX) is the first-line therapy for treatment of RA patients. MTX suppresses proliferation of synovial fibroblasts, modulates cytokine synthesis and superoxide anion production, and inhibits neutrophil chemotaxis.

DRUG

Placebo

Placebo

Trial Locations (1)

Unknown

RECRUITING

Faculty of medicine, Al Mansurah

All Listed Sponsors
lead

Tanta University

OTHER